Close Menu

purchasing agreement

NEW YORK (GenomeWeb News) – The US President's Emergency Plan for AIDS Relief (PEPFAR) this week announced an additional $11 million to provide Cepheid's Xpert MTB/RIF molecular diagnostic platforms and test cartridges for tuberculosis detection in 14 high-burden countries.

NEW YORK (GenomeWeb News) – One day after saying that its third-quarter revenues would fail to meet expectations, Cepheid said on Thursday that it is acquiring a plastics company and bringing at

NEW YORK (GenomeWeb News) – Illumina today said that it has received a $17 million contract from the US Food and Drug Administration to provide sequencing systems and reagents for food safety testing.

NEW YORK (GenomeWeb News) – Cepheid announced the first agreement to buy down the price of the Xpert MTB/RIF test in order to drive adoption of the technology in resource-poor areas of the world with multi-drug-resistant tuberculosis.

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.